Chimerix CMRX

Quarterly report 2024-Q3
added 11-07-2024

Chimerix DIO Ratio 2011-2026 | CMRX

Quarterly DIO Ratio Chimerix

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	565	-	2.47 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.47 K	565	1.52 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	ACADIA Pharmaceuticals ACAD	295	$ 22.57	0.04 %	$ 3.74 B	USA
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Akebia Therapeutics AKBA	147	$ 1.41	-1.4 %	$ 363 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aytu BioScience AYTU	209	$ 2.56	-3.76 %	$ 16.1 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 20.87	2.3 %	$ 976 M	USA
	Aquestive Therapeutics AQST	120	$ 4.17	-0.24 %	$ 446 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Arcutis Biotherapeutics ARQT	185	$ 24.57	-0.16 %	$ 3.13 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA